Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Sale | 2024-12-31 | 13G | Celularity Inc. CELU | BRISTOL MYERS SQUIBB CO BMY | 426,372 1.900% | -768,955 (-64.33%) | Filing History |
| 2025-01-28 4:30 pm Unchanged | 2025-01-24 | 13D | Celularity Inc. CELU | Dragasac Ltd | 9,938,161 36.400% | 0 (Unchanged) | Filing History |
| 2024-12-19 9:16 pm Purchase | 2024-07-15 | 13D | Celularity Inc. CELU | Dragasac Ltd | 9,938,161 36.400% | 1,310,995 (+15.20%) | Filing History |
| 2024-03-15 5:32 pm Purchase | 2024-03-13 | 13D | Celularity Inc. CELU | Dragasac Ltd | 8,627,166 34.200% | 8,627,166 (New Position) | Filing History |
| 2024-02-08 06:00 am Unchanged | 2023-12-31 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 4.110% | 0 (Unchanged) | Filing History |
| 2024-01-17 5:15 pm Purchase | 2024-01-12 | 13D | Celularity Inc. CELU | Dragasac Ltd | 8,327,168 33.600% | 4,326,373 (+108.14%) | Filing History |
| 2023-10-05 5:22 pm Sale | 2023-09-29 | 13G | Celularity Inc. CELU | Sorrento Therapeutics Inc. SRNEQ | 505,043 2.600% | -1,537,170 (-75.27%) | Filing History |
| 2023-06-22 4:36 pm Purchase | 2023-06-20 | 13D | Celularity Inc. CELU | Dragasac Ltd | 4,000,795 21.000% | 341,536 (+9.33%) | Filing History |
| 2023-02-13 5:13 pm Unchanged | 2022-12-31 | 13G | Celularity Inc. CELU | STARR INTERNATIONAL CO INC | 1,528,139 10.540% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:12 pm Purchase | 2022-12-31 | 13G | Celularity Inc. CELU | C V STARR & CO INC | 764,069 5.270% | 764,069 (New Position) | Filing History |
| 2023-02-06 06:01 am Unchanged | 2022-12-31 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 5.500% | 0 (Unchanged) | Filing History |
| 2023-02-03 07:28 am Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 6.510% | 796,885 (New Position) | Filing History |
| 2022-02-04 12:07 pm Unchanged | 2021-12-31 | 13G | Celularity Inc. CELU | Weiss Asset Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-01-27 08:13 am Unchanged | 2021-12-31 | 13G | Celularity Inc. CELU | Highbridge Capital Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-07-26 5:19 pm Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | Human Longevity Inc. | 701,257 5.700% | 701,257 (New Position) | Filing History |
| 2021-07-26 5:16 pm Purchase | 2021-07-16 | 13D | Celularity Inc. CELU | Hariri Robert J | 1,029,667 8.200% | 1,029,667 (New Position) | Filing History |
| 2021-07-26 5:10 pm Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | BRISTOL MYERS SQUIBB CO BMY | 1,195,327 9.900% | 1,195,327 (New Position) | Filing History |
| 2021-07-26 4:12 pm Purchase | 2021-07-16 | 13D | Celularity Inc. CELU | Dragasac Ltd | 3,659,260 28.400% | 3,659,260 (New Position) | Filing History |
| 2021-07-26 12:19 pm Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | STARR INTERNATIONAL CO INC | 1,528,139 11.800% | 1,528,139 (New Position) | Filing History |
| 2021-07-23 06:02 am Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | Sorrento Therapeutics Inc. SRNEQ | 2,042,212 16.700% | 2,042,212 (New Position) | Filing History |